TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OMER

Omeros Corporation

Healthcare · Biotechnology

20.10$ -2.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow OMER
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – – – – – – – – -299.1% –
– +61.6% +15.7% +3.9% +4.7% -7.8% -26.4% -5.6% +7.9% -35.9% +43.5% +83.7% +74.6% +86.1% -9.7% -14.2% -31.3% -3.4% +3.3% +1.5%
– +320.8% -61.8% -35.5% +45.8% -11.5% +122.2% +46.0% +42.6% +7.4% +41.8% -6.6% -7.7% +17.7% +8.3% +18.1% -20.2% -17.2% -9.9% -21.9%
– – – – – – +125.8% +32.0% +54.8% +13.5% +72.8% -18.2% +5.3% -22.4% +24.2% -1,810.5% – – – –
– +551.8% -144.9% – +1,610.3% -98.6% -1,059.1% – +59.6% -147.2% – – – -109.2% – -286.0% – – -88.0% +13.4%
– +221.7% -69.3% +70.1% +2,924.4% -85.3% -48.3% -68.2% -86.3% +757.1% -47.5% +177.8% +62.0% -41.1% -15.3% -2.1% -59.2% +277.0% -61.3% -60.6%
– +952.0% – -595.9% – -15.1% -105.4% – -22.2% -434.7% -20.7% +130.2% – -113.5% +1,870.9% – -165.9% – +199.5% +100.1%
– – – – – – -100.0% – – – – – – – – – – – – –
– – – – – – +926.9% -35.0% +79.9% +117.0% -49.7% +83.1% -91.1% +818.5% +59.6% -91.8% -94.9% -1,221.4% +154.6% -100.0%
– – – – – – -96.6% – – -57.4% +462.4% -101.6% – -98.7% +6,331.0% -99.7% -86.2% -254,050.0% -59.3% +115.7%
– -91.4% +442.9% +274.2% -105.0% – +247.6% -34.3% +134.9% +70.7% -20.9% +9.2% +8.1% -25.1% +187.5% -96.4% +1,866.3% -185.4% – -167.1%
– -175.5% – -275.1% – -70.4% -441.8% – – – -15.0% +36.2% +110.9% -212.6% – +1,117.6% -199.4% – – –
– – – – – – – – – – – – – – – – – – -300.5% –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?